FGF23 beyond mineral metabolism: a bridge to cardiovascular disease
- PMID: 22157705
- PMCID: PMC3255380
- DOI: 10.2215/CJN.10711011
FGF23 beyond mineral metabolism: a bridge to cardiovascular disease
Comment on
-
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.Clin J Am Soc Nephrol. 2011 Nov;6(11):2688-95. doi: 10.2215/CJN.04290511. Epub 2011 Sep 8. Clin J Am Soc Nephrol. 2011. PMID: 21903990 Free PMC article.
References
-
- Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD: Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278: 37419–37426, 2003 - PubMed
-
- Bai X, Miao D, Li J, Goltzman D, Karaplis AC: Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145: 5269–5279, 2004 - PubMed
-
- ADHR Consortium: Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26: 345–348, 2000 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
